help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Lignieres, B.
Right arrow Articles by Guy-Grand, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Lignieres, B.
Right arrow Articles by Guy-Grand, B.

Journal of Clinical Endocrinology & Metabolism, Vol 62, 536-541, Copyright © 1986 by Endocrine Society

ARTICLES

Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration

B De Lignieres, A Basdevant, G Thomas, JC Thalabard, C Mercier-Bodard, J Conard, TT Guyene, N Mairon, P Corvol and B Guy-Grand

To determine whether the route of administration or the type of estrogen used in estrogen replacement therapy (ERT) is more important in avoiding effects on hepatic function, 24 postmenopausal women were studied before and at the end of 2 months of oral or percutaneous administration of the same estrogen, estradiol-17 beta (E2). The treatments studied were oral micronized E2, 2 mg/day (9 women); oral E2 valerate, 2 mg/day (5 women), and percutaneous E2, 3 mg/day (10 women). Specific plasma biological and biochemical markers of estrogenic action were evaluated, namely, E2, estrone (E1), LH, FSH, sex steroid binding protein (SBP), renin substrate, antithrombin activity, and lipoproteins (high density lipoprotein cholesterol, low density lipoprotein cholesterol, very low density lipoprotein triglycerides). Both oral and percutaneous administration of E2 increased plasma E2 levels up to midfollicular values and decreased LH and FSH levels into the same range. Oral administration of E2 led to substantial increases in plasma E1, SBP, renin substrate, and VLDL levels, whereas AT decreased significantly. Percutaneous administration of E2 led to a physiological plasma E1/E2 ratio and did not induce any change in hepatic proteins. These data suggest that the route of administration of E2 determines the biochemical response to ERT in postmenopausal women. SBP is the most sensitive marker of the liver action of estrogen, and triglycerides also are simple and useful markers for this effect. Percutaneous E2 therapy is an effective method of ERT, and has no measurable effects on hepatic markers of estrogen action.


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Coylewright, J. F. Reckelhoff, and P. Ouyang
Menopause and Hypertension: An Age-Old Debate
Hypertension, April 1, 2008; 51(4): 952 - 959.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Sitruk-Ware, G. Plu-Bureau, J. Menard, J. Conard, S. Kumar, J.-C. Thalabard, B. Tokay, and P. Bouchard
Effects of Oral and Transvaginal Ethinyl Estradiol on Hemostatic Factors and Hepatic Proteins in a Randomized, Crossover Study
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2074 - 2079.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
M. Singh, J. A. Dykens, and J. W. Simpkins
Novel Mechanisms for Estrogen-Induced Neuroprotection.
Experimental Biology and Medicine, May 1, 2006; 231(5): 514 - 521.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. M. Mah, J. Webster, P. Jonsson, U. Feldt-Rasmussen, M. Koltowska-Haggstrom, and R. J. M. Ross
Estrogen Replacement in Women of Fertile Years with Hypopituitarism
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5964 - 5969.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
G. G T'Sjoen, Y. Beguin, E. Feyen, R. Rubens, J.-M. Kaufman, and L. Gooren
Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma
J. Endocrinol., July 1, 2005; 186(1): 61 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
S M. HARMAN, F. NAFTOLIN, E. A. BRINTON, and D. R. JUDELSON
Is the Estrogen Controversy Over? Deconstructing the Women's Health Initiative Study: A Critical Evaluation of the Evidence
Ann. N.Y. Acad. Sci., June 1, 2005; 1052(1): 43 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. J Giltay, L. J. Gooren, A. W. Toorians, M. B Katan, and P. L Zock
Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects
Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1167 - 1174.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho
Estrogen Regulation of Growth Hormone Action
Endocr. Rev., October 1, 2004; 25(5): 693 - 721.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
N. Yesildaglar, S. Erkaya, D. Uygur, K. Gol, B. Bingol, and Z. Gunenc
Efficacy of pulsed estrogen therapy in relatively younger patients with surgically induced menopause
Hum. Reprod., January 1, 2004; 19(1): 210 - 213.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
A. Lemay, S. Dodin, N. Kadri, H. Jacques, and J.-C. Forest
Flaxseed Dietary Supplement Versus Hormone Replacement Therapy in Hypercholesterolemic Menopausal Women
Obstet. Gynecol., September 1, 2002; 100(3): 495 - 504.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Fischer, A. Baessler, and H. Schunkert
Renin angiotensin system and gender differences in the cardiovascular system
Cardiovasc Res, February 15, 2002; 53(3): 672 - 677.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Ankarberg-Lindgren, M. Elfving, K. A. Wikland, and E. Norjavaara
Nocturnal Application of Transdermal Estradiol Patches Produces Levels of Estradiol That Mimic Those Seen at the Onset of Spontaneous Puberty in Girls
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3039 - 3044.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. K. Kang, J. A. Duncan, D. C. Cattran, J. S. Floras, V. Lai, J. W. Scholey, and J. A. Miller
Effect of oral contraceptives on the renin angiotensin system and renal function
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R807 - R813.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
P. LOPES, H. M. W. M. MERKUS, J. NAUMAN, F. BRUSCHI, J.-M. FOIDART, and J. CALAF
Randomized Comparison of Intranasal and Transdermal Estradiol
Obstet. Gynecol., December 1, 2000; 96(6): 906 - 912.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
E. J. Giltay, L. J. G. Gooren, J. J. Emeis, T. Kooistra, and C. D. A. Stehouwer
Oral, but Not Transdermal, Administration of Estrogens Lowers Tissue-Type Plasminogen Activator Levels in Humans Without Affecting Endothelial Synthesis
Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1396 - 1403.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Karjalainen, J. Heikkinen, M. J. Savolainen, A.-C. Backstrom, and Y. A. Kesaniemi
Mechanisms Regulating LDL Metabolism in Subjects on Peroral and Transdermal Estrogen Replacement Therapy
Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1101 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Garnero, Y. Tsouderos, I. Marton, C. Pelissier, C. Varin, and P. D. Delmas
Effects of Intranasal 17{beta}-Estradiol on Bone Turnover and Serum Insulin-Like Growth Factor I in Postmenopausal Women
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2390 - 2397.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. C. Duncan, H. Lyall, R.N. Roberts, J. R. Petrie, M. J. Perera, S. Monaghan, D. M. Hart, J. M. C. Connell, and M. A. Lumsden
The Effect of Estradiol and a Combined Estradiol/Progestagen Preparation on Insulin Sensitivity in Healthy Postmenopausal Women
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2402 - 2407.
[Abstract] [Full Text]

Home page
 HypertensionHome page
E. W. Seely, B. W. Walsh, M. D. Gerhard, and G. H. Williams
Estradiol With or Without Progesterone and Ambulatory Blood Pressure in Postmenopausal Women
Hypertension, May 1, 1999; 33(5): 1190 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. L Kuroski de Bold
Estrogen, natriuretic peptides and the renin-angiotensin system
Cardiovasc Res, March 1, 1999; 41(3): 524 - 531.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. Nickenig, A. T. Baumer, C. Grohe, S. Kahlert, K. Strehlow, S. Rosenkranz, A. Stablein, F. Beckers, J. F. M. Smits, M. J. A. P. Daemen, et al.
Estrogen Modulates AT1 Receptor Gene Expression In Vitro and In Vivo
Circulation, June 9, 1998; 97(22): 2197 - 2201.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P.-Y. Scarabin, M. Alhenc-Gelas, G. Plu-Bureau, P. Taisne, R. Agher, and M. Aiach
Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women : A Randomized Controlled Trial
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3071 - 3078.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
P. Corvol and X. Jeunemaitre
Molecular Genetics of Human Hypertension: Role of Angiotensinogen
Endocr. Rev., October 1, 1997; 18(5): 662 - 677.
[Abstract] [Full Text]

Home page
 CirculationHome page
H. Schunkert, A.H. J. Danser, H.-W. Hense, F. H.M. Derkx, S. Kurzinger, and G. A.J. Riegger
Effects of Estrogen Replacement Therapy on the Renin-Angiotensin System in Postmenopausal Women
Circulation, January 7, 1997; 95(1): 39 - 45.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society